10 August 2016 - Deborah Wilkes
Archived
A consortium led by Chinese pharmaceutical company Shanghai Pharma is set to acquire Australian vitamins, minerals and supplements (VMS) specialist Vitaco Holdings in a deal worth A$314 million (US$240 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.